Кальция хлорид 10% 5 мл раствор для инъекций

Country: Kyrgyzstan

Bahasa: Rusia

Sumber: Правительства Кыргызской Республики (Департамент лекарственного обеспечения и медицинской техники)

Bahan aktif:

Кальция хлорид

Boleh didapati daripada:

СП ООО Jurabek laboratories (СП ООО Jurabek laboratories)

Kod ATC:

B05XA07

INN (Nama Antarabangsa):

Calcium chloride

Dos:

10% 5 мл

Borang farmaseutikal:

раствор для инъекций

Unit dalam pakej:

№10

Jenis preskripsi:

по рецепту

Dikeluarkan oleh:

СП ООО Jurabek laboratories (Узбекистан)

Kawasan terapeutik:

Препарат кальция, антиаллергическое средство

Ringkasan produk:

ПЖВЛС: нет

Tarikh kebenaran:

2017-11-20

Ciri produk

,,,
yTBEPXAAK)
Ilepnrrfi
3aMecrureJrb
Ar{pexTopa
TTHCTPyK\mtl
rr
o MEAurIr,rH
c
K
o
MycTllM
JreKapcTBeHHOfO
CKOI{
TEXHIIKI{
2017
r.
HOrO
.{eua
KAJrbrlnrr
xJroPkrA
Topronoe
Ha3BaHr{e
Kamqzs
xnopr4A
MexaynapoAuoe
He[areHToBaHHoe
Ha3BaHr{e
(MHH)
Her
JlercapcrneHnan
Qopna
Pacrnop
4la
uurexqufi.
Cocrae
Arcmueuoe
seu4ecmso:
KaJrbrlr4r
xJropr.rA
(rencarugpar)
-
100
r;
BcnouozamerbHoe
seu4ecmso:
BoAa
Anr
uurerqufi
Ao
I n.
Onucauue
llpospa.+rar,
6ecqneruar
Nu4xbcir.
(DapuarcorepareBTuqecnafl
rpyrra
llrasN'IosaNaelqanuple
u nep$ysvoHHble
pacrBopu.
3nexrpoJrr4THbre
pacrBopbr.
Ka6qur
xJroprr.4.
Koa
ATX:
B05XA07
@apnaarco.noruqecKue
ceofi
crea
(Dapttarcodr.tH&MuKa
LlcroqHzr
uoHoB
Ktulbqt4fl,
urparoqufi
BaxHyro
ponb
B
coKpalrleHrzl4
cKeJrerHbrx
14
rna.4Kr4x
MbrrIJrI,
Ae'[TenbHocrI'I
MhIIxIIbI
cepAIIa,
Ilpollecce
lepeAaqn
HepBHbIx
aMnyJlbcoB,
Soprraupoeanaz
roc.rgofi
TKaHn,
perynl4poBaHul4
npoHI{IIaeMocrH
cocy4ucrofi
creHKII,
cBeprhrBaeMocrr{
KpoBr4.
o6naAae'r
aHTuanJIeprI4qecKI4M
4eficrnueu.
Mexasugu
aHTr4aJrnepruqecKoro
4eficrnur
Helr3BecreH,
oAHaKo
npl{
BHyrpIaBeHHoM
BBeAeHI4I4
colefi
KaJIbII}If,
BbI3bIBaer
nor6yN4enr4e
cr4Mrrar""a"*ofi
Hepuuofi
cr4creM6r
U
y
cn neHve
BbrAen
eHlrr
HaAnoqeqH
r4KaMU
aApe
HaJrr,rHa.
Iforcagau[s
K
rrprrMeHeHuro
llpu
annepruqecKl4x
:a6oreaaHlrtx
(cuuopo:roquofi
6oresuu,
Kpanr,rBHr4qe,
aHrr4oHeBport4rrecKoM
oreKe,
cesuoft
JII4xopa.{Ke
v r.A.)
14
anrepruqecKl4x
ocJroxHeHr4rx,
cBr3aHH6rx
c [ppreMoM
JreKapcrB,
rIpI4 yCUneHHoM
BLIAeIreHvMarbIII4q
Ir3
OpfaHr43Me,
qro
MOXer
l,rMerb
Mecro
rrpr,r
Anr{Telruofi
lrNtNaoourzsau,la
6omuoro,
6epeueuHocru;
KaK
cpeAcrBo,
yMeHbrxaroqee
[poHr{rlaeMocrb
cocyAoB'
npI'I
feMopparl4qecKoM
BacKyJII4Te,
tBJIeHI4tx
lyvenofi
6onaatt,
npr,r
BocnaJrI{TeJTbHLIX
H
sKccyAarI4BHbIX
npoqeccax
(lHenuoulll4,
rIJIeBpI,ITe,
nJreKcr4Te,
gHAoMerp
vrre
u
,qp.);
xoNsux
paHp'rtrs
3a6oneBaHl4qx
(3yA,
gK3eMa,
ncoplra3
u
Ap.),
npv
HeAocraror{Hofi (fynrcquu
[apaulprroBr4AHbrx
xeJle3
(reranuu),
paxl4Te
(cna:rr,ro(prznur.r);
[pr4
rrapeHxr4Maro3HoM
rerraruTe,
ToKcuqecKr.rx
lopax(eHl4tx
neqeHLI,
H